PAGB Updated Briefing Paper on Titanium Dioxide PAGB's briefing paper – ‘PAGB overview relating to the ban of titanium dioxide in foods, including its potential impact on food supplements and medicines’ has been updated. PAGB Updated Briefing Paper on Titanium Dioxide
EMA HMPC Meeting Report – September 2025 The report on European Union herbal monographs, guidelines, and other activities from the European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) meeting held on 22-24 September 2025 has been published. EMA HMPC Meeting Report – September 2025
MHRA Marketing Authorisations Granted 15 to 30 September 2025 MHRA granted 4 OTC licences during 15 - 30 September 2025. MHRA Marketing Authorisations Granted 15 to 30 September 2025
EUROTALC Scientific Position Published EUROTALC, the talc industry’s representative body for regulatory and scientific matters, has published its position regarding the European Chemicals Agency's (ECHA) Harmonised Classification Proposal of Talc. EUROTALC Scientific Position Published
European Medicines Agencies Network Data Strategy The European Medicines Agency (EMA) / Heads of Medicines Agencies (HMA) have published their European Medicines Agencies Network Data Strategy. This strategy sets out the agreed European medicines regulatory network (EMRN) vision, principles to be followed and goals to be met to maximise the value of the data managed by the EMRN. European Medicines Agencies Network Data Strategy
EDQM – Guidelines on Considerations Issuing Recommendations on Classification of Active Substances as Regards Their Supply The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published the new guidelines on the classification of active pharmaceutical substances as regards their supply (prescription and non-prescription status). EDQM – Guidelines on Considerations Issuing Recommendations on Classification of Active Substances as Regards Their Supply
FSA Consultation – Proposed BPA Ban, Alignment With the EU The FSA has launched a public consultation seeking stakeholders’ views on their proposal to implement a ban on the use of bisphenol A (BPA) and other bisphenols in food contact materials (FCMs). The consultation will close on 24 December 2025. FSA Consultation – Proposed BPA Ban, Alignment With the EU
AESGP Webinar – Evaluating Credibility in Digital Campaigns AESGP is hosting a webinar on “Evaluating credibility in digital campaigns: a practical guide and example with Influencer Monitor" on 24 November. AESGP Webinar – Evaluating Credibility in Digital Campaigns
OTC Medicines Pack Design Workshop – Join Us on 6 November The PAGB OTC Medicines Pack Design Workshop is taking place in person at the PAGB office on 6 November from 10am to 4pm. OTC Medicines Pack Design Workshop – Join Us on 6 November
MHRA Medicines Marketing Authorisation: Change of Ownership Form Update MHRA has updated the change of ownership form found in the guidance 'medicines marketing authorisation: change of ownership' which contains information on how to change the ownership from one marketing authorisation (MA) holder to another. MHRA Medicines Marketing Authorisation: Change of Ownership Form Update
European Commission Survey on Draft Guidance on Article 73 AI Act – Incident Reporting The European Commission has launched a targeted stakeholder consultation on the Commission guidance on Article 73 of the AI act which concerns incident reporting (High-Risk AI Systems). European Commission Survey on Draft Guidance on Article 73 AI Act – Incident Reporting
EU AI in Medicine Survey: Stakeholder Priorities to Inform Research and Regulatory Agenda The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) Network Data Steering Group (NDSG) is running a survey to inform research priorities for AI use in the development and evaluation of medicines. EU AI in Medicine Survey: Stakeholder Priorities to Inform Research and Regulatory Agenda
